Gujarat Themis Biosyn P/E Ratio
Current P/E Ratio
117.28
High Valuation
Very High - High growth expectations or significantly overvalued
Gujarat Themis Biosyn (GUJTHEM) P/E ratio is 117.28 (High), EPS (TTM) ₹4.28, current price ₹427.40 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see GUJTHEM screener.
Current Valuation Metrics
P/E Ratio
117.28
Current Price
₹427.40
EPS (TTM)
₹4.28
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
56.49
Sector Median
31.66
Sector Rank
#11 of 199
Sector Percentile
5.5%
Earnings Breakdown (TTM)
TTM EPS
₹2.85
Mar 2026
₹1.00
Jun 2026
₹1.02
GUJTHEM P/E Ratio — Valuation Signal & Historical Context
Gujarat Themis Biosyn P/E 117.28 — signal: Overvalued. Also explore GUJTHEM share price history to track price trends across different timeframes.
- Stock appears overvalued with PE of 117.28, suggesting caution for new investments
- Trading at premium to sector average PE of 56.49
GUJTHEM vs Healthcare Peers — P/E Ratio Comparison
Gujarat Themis Biosyn P/E 117.28 vs Healthcare average 56.49, median 31.66 — range 1.99–747.21.
Sector Average
56.49
Sector Median
31.66
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |